DADO MEDICAL s.r.o.
- Address
- Senovazne namesti 992/8, 110 00 Prague, Czechia
Chronic Migraine
DADO MEDICAL s.r.o. in Prague focuses on Nervous System Diseases, specifically studying chronic migraine. The trial aims to assess the effectiveness and safety of Dysport as a preventive treatment, seeking to lower the number of monthly migraine days in adults.
- Efficacy of botulinum toxin for migraine prevention
- Reduction of monthly migraine days
- Safety profile in adult patients
- Impact on daily functioning and quality of life
The study welcomes adults with frequent migraine attacks and contributes to expanding therapeutic options for long‑term migraine management.
Episodic Migraine
At DADO MEDICAL s.r.o., researchers in Prague are investigating episodic migraine within the broader field of Nervous System Diseases. The objective is to evaluate how Dysport can safely prevent migraine episodes and reduce monthly migraine days for adult participants.
- Prevention of episodic migraine attacks
- Measurement of monthly migraine day reduction
- Assessment of tolerability in a real‑world setting
- Patient‑reported outcomes on headache burden
This investigation aims to provide clearer guidance for clinicians treating patients who experience intermittent migraine symptoms.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Ipsen Innovation2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 634 other sites in Czechia
Therapeutic Area Benchmark — Czechia
Select a therapeutic area to compare against other sites in Czechia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Czechia
Market Share
Country: Czechia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in DADO MEDICAL s.r.o.
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety Evaluation of Botulinum Toxin Type A in Chronic Migraine Prevention in Adults: A Randomized, Double-Blind, Placebo-Controlled Study | Ipsen Innovation | Phase III | Not Recruiting | Mar 2024 | — |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Botulinum Toxin Type A - Haemagglutinin Complex | 2 | Unknown | 2024-03-18 | 2024-03-18 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.